当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第29期
编号:13445555
艾滋病肠病与炎症性肠病的鉴别和作用关系研究进展(5)
http://www.100md.com 2019年10月15日 《中国医药导报》 2019年第29期
     [21] James SP. Remission of Crohn′s disease after human immunodeficiency virus infection [J]. Gastroenterology,1988, 95(6):1667-1669.

    [22] Pospai D,René E,Fiasse R,et al. Crohn′s disease stable remission after human immunodeficiency virus infection [J]. Dig Dis Sci,1998,43(2):412-419.

    [23] Viazis N,Vlachogiannakos J,Georgiou O,et al. Course of inflammatory bowel disease in patients infected with human immunodeficiency virus [J]. Inflamm Bowel Dis,2010,16(3):507-511.

    [24] 中華医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年·北京)[J].中国实用内科杂志,2018,38(9):796-813.

    [25] Magro F,Gionchetti P,Eliakim R,et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions,diagnosis,extra-intestinal manifestations,pregnancy,cancer surveillance,surgery,and ileo-anal pouch disorders [J]. J Crohns Colitis,2017,11(6):649-670.

    [26] 王译葵,陈晓晨,王继宝,等.德宏傣族景颇族自治州2016年HIV/HCV合并感染者HCV分子传播簇分析[J].中华流行病学杂志,2019,40(2):191-195.

    [27] Brunasso AM,Puntoni M,Gulia A,et al. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection:a systematic review [J]. Rheumatology(Oxford),2011,50(9):1700-1711.

    (收稿日期:2019-04-22 本文编辑:顾家毓), 百拇医药(刘欢宇 冉艳 米琛 厉英超)
上一页1 2 3 4 5